Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). IDEXX Laboratories's share price for the quarter that ended in Mar. 2026 was €481.7. IDEXX Laboratories's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 79 Mil. Therefore, IDEXX Laboratories's market cap for the quarter that ended in Mar. 2026 was €38,170 Mil.
IDEXX Laboratories's quarterly market cap
increased
from Sep. 2025 (€31,744 Mil) to Dec. 2025 (€45,340 Mil) but then
declined
from Dec. 2025 (€45,340 Mil) to Mar. 2026 (€38,170 Mil).
IDEXX Laboratories's annual market cap
declined
from Dec. 2023 (€41,798 Mil) to Dec. 2024 (€32,380 Mil) but then
increased
from Dec. 2024 (€32,380 Mil) to Dec. 2025 (€45,340 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. IDEXX Laboratories's Enterprise Value for Today is €40,419 Mil.
IDEXX Laboratories (XTER:IX1) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
IDEXX Laboratories Market Cap Related Terms
IDEXX Laboratories Market Cap Historical Data
* Premium members only.
The historical data trend for IDEXX Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDEXX Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
IDEXX Laboratories's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (XTER:IX1) has a Market Cap of €39,634 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on IDEXX Laboratories and its competitors. According to the industry distribution chart, IDEXX Laboratories ranks #5 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 2.3%.
Is IDEXX Laboratories' Market Cap too high?
IDEXX Laboratories' current Market Cap is €39,634 Mil. Based on the distribution chart, IDEXX Laboratories ranks #5 out of 219 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, IDEXX Laboratories has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Market Cap compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #5 out of 219 companies for Market Cap. This places IDEXX Laboratories in the top 2% of its industry — outperforming the majority of peers. The industry median Market Cap is 55.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 55.76, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on IDEXX Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 55.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEXX Laboratories's current Market Cap is €39,634 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
IDEXX Laboratories (XTER:IX1) has a current Market Cap of €39,634 Mil. The stock's GF Value™ is €559.26, compared to a current price of €488.90 — trading 12.6% below its estimated fair value. The current Market Cap is €39,634 Mil. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For IDEXX Laboratories (XTER:IX1), the current Market Cap is €39,634 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEXX Laboratories (XTER:IX1) Overvalued in 2026?
Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued.
The current stock price of €488.90 is trading 12.6% below its estimated GF Value™ of €559.26.
Key valuation signals for XTER:IX1:
Market Cap: €39,634 Mil
GF Value™: €559.26 vs. price of €488.90 (12.6% below fair value)
No single metric tells the full story. See the XTER:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score
Get the complete analysis for XTER:IX1
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:IX1 has been successfully added to your 
